Stock Analysis on Net
Stock Analysis on Net

Shockwave Medical Inc. (NASDAQ:SWAV)

Common-Size Income Statement
Quarterly Data

Shockwave Medical Inc., common-size consolidated income statement (quarterly data)

Microsoft Excel
3 months ended: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Product revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Revenue 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Cost of product revenue -12.47 -13.18 -13.59 -13.08 -12.15 -13.61 -13.86 -13.77 -15.04 -16.80 -17.77 -24.74 -28.49 -26.94 -34.92 -37.18 -38.80 -38.83 -41.28 -42.26
Cost of revenue -12.47% -13.18% -13.59% -13.08% -12.15% -13.61% -13.86% -13.77% -15.04% -16.80% -17.77% -24.74% -28.49% -26.94% -34.92% -37.18% -38.80% -38.83% -41.28% -42.26%
Gross profit 87.53% 86.82% 86.41% 86.92% 87.85% 86.39% 86.14% 86.23% 84.96% 83.20% 82.23% 75.26% 71.51% 73.06% 65.08% 62.82% 61.20% 61.17% 58.72% 57.74%
Research and development -20.85 -21.25 -20.44 -16.75 -16.47 -15.36 -17.19 -18.18 -17.48 -21.08 -21.13 -32.22 -39.81 -40.28 -78.76 -78.24 -70.39 -73.84 -69.18 -102.96
Sales and marketing -33.10 -30.59 -31.49 -33.53 -30.16 -32.04 -33.55 -38.41 -39.43 -43.58 -45.99 -75.21 -72.35 -69.52 -108.94 -68.51 -67.04 -72.28 -69.53 -80.77
General and administrative -12.26 -11.53 -16.50 -11.92 -11.76 -10.99 -10.90 -13.23 -11.44 -14.22 -15.43 -22.65 -29.19 -28.64 -52.48 -40.96 -31.10 -30.33 -32.41 -41.28
Operating expenses -66.20% -63.37% -68.44% -62.20% -58.39% -58.40% -61.65% -69.82% -68.35% -78.88% -82.55% -130.08% -141.36% -138.44% -240.18% -187.70% -168.53% -176.45% -171.11% -225.01%
Income (loss) from operations 21.32% 23.45% 17.97% 24.72% 29.46% 27.99% 24.49% 16.42% 16.61% 4.32% -0.32% -54.82% -69.85% -65.38% -175.10% -124.89% -107.33% -115.28% -112.40% -167.27%
Income (loss) from equity method investment -0.08 -0.39 -0.08 -0.51 -0.74 0.07 -1.21 -0.05 -0.50 -0.52 0.00 -17.31 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest expense -1.45 -1.35 -0.45 -0.39 -0.67 -0.24 -0.25 -0.32 -0.36 -0.25 -0.57 -0.98 -1.39 -1.60 -2.97 -1.82 -1.38 -2.21 -2.50 -3.37
Change in fair value of warrant liability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -8.38
Other income (expense), net 7.54 2.53 0.88 1.48 2.96 -1.08 -1.22 -0.33 -0.25 -0.43 0.26 -0.74 1.38 1.11 2.14 3.32 5.77 3.40 9.12 3.04
Net income (loss) before taxes 27.32% 24.23% 18.32% 25.29% 31.00% 26.74% 21.81% 15.72% 15.50% 3.11% -0.63% -73.85% -69.85% -65.87% -175.94% -123.39% -102.94% -114.10% -105.77% -175.98%
Income tax (provision) benefit -5.50 -5.43 -2.30 -1.00 66.83 -0.09 -0.64 -0.21 -0.13 -0.12 -0.13 -0.14 -0.03 -0.15 -0.20 -0.15 -0.08 -0.23 -0.18 -0.10
Net income (loss) 21.83% 18.81% 16.02% 24.29% 97.84% 26.65% 21.17% 15.51% 15.37% 2.99% -0.76% -73.98% -69.88% -66.01% -176.14% -123.54% -103.02% -114.33% -105.95% -176.08%

Based on: 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Income statement item Description The company
Income (loss) from operations The net result for the period of deducting operating expenses from operating revenues. Shockwave Medical Inc. income (loss) from operations as a percentage of revenue increased from Q2 2023 to Q3 2023 but then slightly decreased from Q3 2023 to Q4 2023.
Net income (loss) before taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Shockwave Medical Inc. net income (loss) before taxes as a percentage of revenue increased from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023.
Net income (loss) The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Shockwave Medical Inc. net income (loss) as a percentage of revenue increased from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023.